The difference between a GH peptide that stirs hunger and one that does not comes down to a single receptor. GHRPs bind the ghrelin receptor, the body’s hunger switch. GHRH analogs such as sermorelin do not touch it.
Some growth hormone peptides increase appetite and some do not, and which is which is predictable from the receptor each one binds. GHRPs, the growth hormone secretagogues like ipamorelin, GHRP-6, and GHRP-2, act on the ghrelin receptor, the same receptor the body’s hunger hormone uses. GHRH analogs like sermorelin, CJC-1295, and tesamorelin act on a different receptor and do not signal hunger directly. If appetite is a concern, the class of peptide matters more than the dose.
- GHRPs (secretagogues) bind the ghrelin receptor, the receptor that drives hunger [1]
- GHRH analogs (sermorelin, CJC-1295, tesamorelin) bind the GHRH receptor and do not directly stimulate appetite [2][3]
- Among GHRPs, GHRP-6 is the strongest appetite stimulant; ipamorelin is the most selective and mildest [1]
- For a weight-focused patient who wants to avoid added hunger, a GHRH analog is the more logical starting point
- Growth hormone itself promotes fat loss over months; the appetite question is about the delivery peptide, not GH [4]
Why Some GH Peptides Trigger Hunger
The mechanism is the ghrelin receptor. Ghrelin is the body’s principal hunger hormone, and its receptor, GHS-R1a, sits on the pituitary and in appetite-regulating regions of the brain. GHRPs were designed to activate that receptor to release growth hormone. Ipamorelin is described as the first selective growth hormone secretagogue and works as a ghrelin receptor agonist [1]. Activating a hunger receptor to get a GH pulse means appetite stimulation is built into the mechanism, not a random side effect.
The size of that effect varies across the class. GHRP-6 is the member most associated with a strong hunger response. Ipamorelin, the selective one, produces a milder appetite effect for the same GH release [1], which is one reason it displaced the older peptides in clinical practice.
Why Sermorelin and Other GHRH Analogs Do Not
GHRH analogs work through a separate receptor. Sermorelin is a 29-amino acid analog of growth hormone-releasing hormone that binds the GHRH receptor on the pituitary [2]. CJC-1295 is a long-acting GHRH analog acting on the same GHRH receptor [3]. Neither engages the ghrelin receptor, so neither carries the built-in hunger signal that defines the GHRP class.
This is a genuine clinical distinction, not a marketing one. A patient using sermorelin for body composition is not fighting a drug-induced increase in appetite while trying to hold a caloric deficit. A patient on a GHRP, particularly a non-selective one, may be.
The Appetite Ranking, Practically
| Peptide | Class | Receptor | Appetite effect |
|---|---|---|---|
| GHRP-6 | GHRP / secretagogue | Ghrelin (GHS-R1a) | Strong, commonly reported |
| GHRP-2 | GHRP / secretagogue | Ghrelin (GHS-R1a) | Moderate to strong |
| Ipamorelin | GHRP / secretagogue | Ghrelin (GHS-R1a) | Mild, selective [1] |
| Sermorelin | GHRH analog | GHRH receptor | None expected [2] |
| CJC-1295 | GHRH analog | GHRH receptor | None expected [3] |
| Tesamorelin | GHRH analog | GHRH receptor | None expected |
What This Means If You Are Managing Weight
If your goal is fat loss and you want to avoid added hunger, start from the GHRH side. Sermorelin and the other GHRH analogs raise GH and IGF-1 without switching on the ghrelin pathway, so the fat-metabolism effect of GH is not undercut by a stronger drive to eat. In GHRH-analog studies, visceral fat reduction developed over roughly 6 months [4], a gradual effect rather than rapid loss.
If you are stacking a GHRP for its GH response, ipamorelin is the selective choice that keeps the appetite effect smallest [1]. Appetite from a ghrelin agonist is also dose-related and timing-related: a bedtime dose taken on an empty stomach concentrates the effect during sleep, when it is least likely to drive intake.
Growth hormone peptides are not appetite drugs in either direction. A GHRH analog does not suppress appetite the way a GLP-1 medication does, and a GHRP does not increase it the way a dedicated appetite stimulant would. The distinction here is only whether the peptide adds hunger on top of your baseline, and the GHRH analogs do not.
Whether a GHRH analog or a selective secretagogue fits depends on your goal and your labs, starting with a baseline IGF-1. SystemLabs tests IGF-1 before prescribing and works across both classes, so the choice is made on your numbers rather than a default protocol.
Bottom Line
Frequently Asked Questions
Do growth hormone peptides make you hungry?
Only one of the two classes does. GHRPs, the growth hormone secretagogues like ipamorelin, GHRP-6, and GHRP-2, activate the ghrelin receptor, which is the body’s hunger receptor, so they can increase appetite [1]. GHRH analogs like sermorelin and CJC-1295 bind a different receptor and do not directly stimulate hunger [2][3]. So the answer depends entirely on which peptide you are using.
Does sermorelin increase appetite?
No, not directly. Sermorelin is a GHRH analog that binds the GHRH receptor, not the ghrelin receptor [2], so it does not carry the hunger signal that defines the GHRP class. That is a practical advantage for someone using it for fat loss, because it does not add appetite while they are holding a caloric deficit.
Does ipamorelin increase appetite?
It can, but less than the older GHRPs. Ipamorelin is a ghrelin receptor agonist, so appetite stimulation is part of its mechanism, but as the selective member of the class it produces a milder hunger effect than GHRP-6 for the same GH release [1]. Taking it at bedtime on an empty stomach limits how much that effect influences daytime intake.
Which GH peptide increases appetite the most?
GHRP-6 is the one most associated with a strong hunger response, because it is a potent, non-selective ghrelin receptor agonist [1]. GHRP-2 is moderate to strong. Ipamorelin is mild. The GHRH analogs, sermorelin, CJC-1295, and tesamorelin, are not expected to increase appetite at all because they do not bind the ghrelin receptor.
Do GH peptides help with weight loss?
Growth hormone promotes fat metabolism, and GHRH-analog studies showed visceral fat reduction over roughly 6 months [4], but GH peptides are not rapid weight-loss drugs and do not replace a caloric deficit. If avoiding added hunger matters, a GHRH analog such as sermorelin is the more logical choice because it raises GH without activating the appetite-driving ghrelin receptor [2].
References
- Ipamorelin, the first selective growth hormone secretagogue European Journal of Endocrinology, 1998. PMID: 9849822. https://pubmed.ncbi.nlm.nih.gov/9849822/
- Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency BioDrugs, 1999. PMID: 18031173. https://pubmed.ncbi.nlm.nih.gov/18031173/
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults Journal of Clinical Endocrinology & Metabolism, 2006. PMID: 16352683. https://pubmed.ncbi.nlm.nih.gov/16352683/
- Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies Growth Hormone & IGF Research, 2015. PMC4324360. https://pmc.ncbi.nlm.nih.gov/articles/PMC4324360/
